Latest stories on PCRX
Pacira initiated with a Market Perform at Leerink amid ‘formulary inertia’
The Fly52 · neutralanalyst
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Pacira initiated with a Market Perform at Leerink
The Fly50 · neutralanalyst
PharmaCorp Rx Inc. Announces Second Quarter 2026 Financial Results
GlobeNewswire71 · bullishearnings
Pacira reinstated with a Buy at Truist
The Fly61 · neutralanalyst
Pacira (PCRX) Q2 2026 Earnings Call Transcript
Yahoo Finance56 · neutralearnings
Pacira (PCRX) Q2 2026 Earnings Call Transcript
The Motley Fool56 · neutralearnings
Pacira BioSciences: Reimbursement Is Turning An Old Franchise Into A New Growth Platform
Seeking Alpha67 · bullishproduct/pr
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases
StockTitan67 · bullishproduct/pr
Pacira BioSciences, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Pacira outlines $735M-$760M 2026 revenue guidance while targeting 160M EXPAREL covered lives
Seeking Alpha63 · neutralgeneral
Pacira BioSciences, Inc. (PCRX) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Pacira BioSciences Reports Second Quarter 2026 Financial Results
StockTitan56 · neutralearnings
Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce
StockTitan54 · neutralgeneral
Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process
StockTitan63 · neutralproduct/pr
Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026
StockTitan50 · neutralearnings
MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth
PR Newswire63 · neutralproduct/pr
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
PharmaCorp Closes Previously Announced Eight-Store Acquisition and Provides Acquisition Pipeline Update
GlobeNewswire63 · neutralm&a
Pacira BioSciences Announces UnitedHealthcare Now Provides Separate Reimbursement for EXPAREL® | PCRX Stock News
StockTitan63 · neutralproduct/pr
Pacira divesting iovera° unit to Zimmer Biomet
Seeking Alpha58 · neutralm&a
Pacira BioSciences Divests CryoTech to Zimmer Biomet
TipRanks55 · neutralm&a
Pacira BioSciences, Inc. (PCRX) files 8-K
SEC 8-K50 · neutralgeneral